Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Medroxyprogesterone 150mg/1ml inj pre-filled syringes
0703022M0AAABAB
|
Medroxyprogest acetate (Contraceptive) | Medroxyprogesterone acetate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 47,707 |
|
Medroxyprogesterone 104mg/0.65ml inj pf disposable devices
0703022M0AAACAC
|
Medroxyprogest acetate (Contraceptive) | Medroxyprogesterone acetate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1,273 |
|
Medroxyprogesterone 150mg/1ml suspension for injection vials
0703022M0AAAAAA
|
Medroxyprogest acetate (Contraceptive) | Medroxyprogesterone acetate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 28 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.